FME AG reported strong nine-month financial performance for the period ending September 30, 2025. Total Revenue grew 2% to €14.56 billion, driven by significant growth in Insurance Contracts revenue and the new Value-Based Care (VBC) segment. Operating Income increased 9% (11% Constant Currency, CC), and Net Income attributable to shareholders surged 38% (41% CC) to €651 million, yielding an EPS of €2.22. Q3 EPS was €0.94. SG&A expenses decreased year-over-year.
Balance Sheet and Capital Management: The Net Leverage Ratio improved to 2.6x. Total Assets contracted to €30.89 billion, and To
...